News Quantified

BPTH – bio-path holdings, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Bio-Path Holdings Reports Full Year 2024 Financial Results

Bio-Path Holdings, Inc. (NASDAQ: BPTH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients [Yahoo! Finance]

-14.0%

BEAT

-3.8%

BEAT

-13.2%

MISS

Form 1-A BIO-PATH HOLDINGS, INC.

Form RW BIO-PATH HOLDINGS, INC.

Form 8-K BIO-PATH HOLDINGS, INC. For: Mar 28

Form 8-K BIO-PATH HOLDINGS, INC. For: Mar 28

Form 10-K BIO-PATH HOLDINGS, INC. For: Dec 31

Top News Gainers

7/16 Bio-Path Holdings Inc (NASDAQ: BPTH) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 22.9%

4/13 Bio-Path Holdings to Present at the 2020 American Association for Cancer Research Annual Meeting 12.4%

2/12 Form S-8 BIO-PATH HOLDINGS INC 7.7%

10/11 Bio-Path Holdings Inc (NASDAQ: BPTH) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. 6.3%

2/3 Bio-Path Holdings Inc (NASDAQ: BPTH) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 5.1%

2/28 Bio-Path Holdings to Announce Fourth Quarter and Full Year 2019 Financial Results on March 6, 2020 4.4%

11/26 Form 8-K BIO-PATH HOLDINGS INC For: Nov 26 4.0%

11/15 Bio-Path Holdings, Inc (BPTH) CEO Peter Nielsen on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 2.4%

8/14 Q2/2019 6/30/2019 EPS -0.870 ZacksConsensus -0.600 ActVsEst (0.270) - Miss 1.8%

3/20 Form 4 BIO-PATH HOLDINGS INC For: Mar 18 Filed by: Nielsen Peter Henry 1.5%

Top News Decliners

11/21 Form 8-K BIO-PATH HOLDINGS INC For: Nov 21 -35.1%

3/6 Bio-Path slips 4% on FY results [Seeking Alpha] -14.7%

3/9 Bio-Path Holdings Inc (NASDAQ: BPTH) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -12.3%

9/25 Form 8-K BIO-PATH HOLDINGS INC For: Sep 25 -11.3%

11/26 Bio-Path Holdings Announces Successful Completion of Safety Testing in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia -10.6%

12/4 Bio-Path Holdings Inc (NASDAQ: BPTH) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.00 price target on the stock. -9.7%

3/11 Bio-Path Holdings Appoints Ernst & Young as New Auditor -9.2%

1/8 Form 8-K BIO-PATH HOLDINGS INC For: Jan 08 -8.7%

9/24 Bio-Path Holdings Inc (NASDAQ: BPTH) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -7.9%

3/31 Form 4 BIO-PATH HOLDINGS INC For: Mar 27 Filed by: Molsbergen Tamaro Martina -7.8%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day